Inter Pharma PCL (BKK:IP)

Market Cap	1.97B
Revenue (ttm)	1.96B
Net Income (ttm)	47.42M
Shares Out	605.34M
EPS (ttm)	0.08
PE Ratio	41.62
Forward PE	n/a
Dividend	0.02 (0.65%)
Ex-Dividend Date	n/a

Volume	17,362
Average Volume	355,605
Open	3.240
Previous Close	3.280
Day's Range	3.240 - 3.300
52-Week Range	2.020 - 5.150
Beta	0.41
RSI	54.30
Earnings Date	Aug 8, 2025

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2024, Inter Pharma PCL's revenue was 1.91 billion, an increase of 6.29% compared to the previous year's 1.80 billion. Earnings were 37.28 million, a decrease of -26.60%.